Search for: "Eli Lilly "
Results 1421 - 1440
of 2,131
Sorted by Relevance
|
Sort by Date
28 Sep 2011, 1:56 am
(Kluwer Patent Blog) Gabitril (Tiagabine) – US: Cephalon files suits against Sun Pharma. in New Jersey and Michigan in response to Para IV certification (Patent Docs) Glivec (Imatinib) – India: Novartis Glivec patent case: preliminary objection (Spicy IP) Lovenox (Enoxaparin) – US: Momenta files patent infringement complaint against Amphastar in response to impending launch of generic Lovenox (Patent Docs) Lumigan (Bimatoprost) – US: Validity of Allergan Lumigan patents… [read post]
1 Apr 2008, 10:57 am
Whether the trial court erroneously interpreted Thomas's Third Commercial Guaranty when calculating the damage award.In Eli Lilly and Company and Mark Hughes v. [read post]
18 Aug 2008, 9:24 pm
.; and, The October 2007 so-called "Dear Doctor" letter about Byetta from Amylin Pharmaceuticals, Inc. and Eli Lilly and Company. [read post]
13 Nov 2012, 4:40 pm
(Eli Lilly & Co., which marketed the diabetes drug for Takeda in the US, is also a common defendant.) [read post]
18 Feb 2014, 3:18 pm
Products in this category are: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Testosterone is a 19-carbon steroid hormone. [read post]
5 Apr 2014, 4:25 pm
Thousands of product liability lawsuits have been filed against Takeda Pharmaceuticals and Eli Lilly, the drug mamanufacturers for failure to research the medication and failure to provide sufficient warnings to patients and doctors. [read post]
5 Sep 2012, 3:30 pm
Meantime, more people are coming forward to file their Actos lawsuits against drug maker Takeda Pharmaceuticals, its subsidiaries, and Eli Lilly, which has been active in marketing the diabetes drug in the US. [read post]
30 Jul 2015, 11:50 am
., Corning Incorporated, Eli Lilly and Company, General Electric, Honda, IBM, Illinois Tool Works Inc., Intel, International Fragrance Association, North America, Johnson & Johnson, Medtronic, Micron, National Alliance for Jobs and Innovation (NAJI), National Association of Manufacturers (NAM), NIKE, The Procter & Gamble Company, Siemens Corporation, Software & Information Industry Association (SIIA), U.S. [read post]
9 Mar 2009, 4:44 am
Those companies surveyed by Towers Perrin are: Merck, Abbott Laboratories, Amgen, Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Hoffman-LaRoche, Johnson & Johnson, Novartis, Pfizer, Sanofi-Aventis, Schering-Plough, and Wyeth.You'll notice that list contains 14 companies â€â [read post]
8 Apr 2008, 12:25 am
``Without immediate action, injuries and deaths from an overwhelmed regulatory system are certain, and the costs to our society will be far greater than any dollar figure upon which we can arrive,'' Cassell, vice president of scientific affairs at Eli Lilly & Co., told the investigative subcommittee of the House Energy and Commerce Committee.The Science Board report described rapidly developing advances in areas such as genomics, wireless health-care devices and… [read post]
8 Mar 2007, 2:26 am
Thus: A Short Primer on the Retaining Lien.Bob Kraft's P.I.S.S.D. points out from Dallas that the FDA Update on Peanut Butter Recall: Salmonella found in the ConAgra Plant.Moving on to drugs, Law.com reports on this case from Britain's High Court: Overmedicated Lawyer Awarded $2.7 Million right on the heals of a new domestic report on medication errors after surgery.For those following the Zyprexa litigation, Pennsylvania has sued Eli Lilly and others for fraudulently… [read post]
27 Dec 2007, 8:42 am
Balducci was a partner -- to pursue Eli Lilly. [read post]
16 Apr 2010, 7:52 am
Maybe it was my treatment of lawyers like they were Cialis - something Eli Lilly and Company works hard to brand. [read post]
22 Jan 2010, 5:26 am
Eli Lilly pleaded guilty to a misdemeanor last January in a nearly $1.5 billion settlement of criminal and civil charges that the pharmaceutical company had marketed Zyprexa, the antipsychotic drug for the treatment of dementia with elderly people. [read post]
26 Feb 2013, 9:02 am
stubid=20311 Testimonials: "Excellent overviews of AIA from those who wrote it, those who will implement it, and those who must live with it" - Graham Douglas, IDDEX (2012) "Assessments and points of view you won't find any place else" - Jim Farmer, Georgetown University (2012) You will network with: Accuray Inc, Americas Bankers Association, Boeing Company, CIENA, Department of Homeland Security, Eldelman, El Cap Ventures, Eli Lilly & Company, Embassy of Canada,… [read post]
16 Jun 2010, 7:43 am
Features of note include "Invalidity for lack of Industrial Application - The Court of Appeal hands down its decision in ELi Lilly & Co. v Human Genome Sciences Inc", by the IPKat's friend and IPSoc founder Charlotte Weekes (now with Pinsent Masons).The new UK coalition government is publishing an emergency budget next Tuesday, 22 June. [read post]
19 Jan 2011, 7:09 am
Lawsuits filed against the drug manufacturer, Xanodyne Pharmaceuticals, and Eli Lilly (the pioneer of the drug) are beginning to grow steadily as individuals learn about the danger they have been relegated to by taking such harmful prescription drugs. [read post]
12 Sep 2017, 4:00 am
The doctrine of collateral estoppel has two requirements: (1) “the identical issue necessarily must have been decided in the prior action and be decisive of the present action,” and (2) “the party to be precluded from relitigating the issue must have had a full and fair opportunity to contest the prior determination” (Kaufman v Eli Lilly & Co., 65 NY2d 449, 455 [1985]; see Ackman v Haberer, 111 AD3d 1378, 1379 [2013]). [read post]
8 Sep 2009, 4:00 am
Earlier this year, Indianapolis-based Eli Lilly & Co. agreed to pay $1.42 billion to settle a case over the marketing of its top seller, Zyprexa, an anti-psychotic drug. [read post]
23 Sep 2009, 4:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC upholds patentability of drug dosage method claim: Prometheus v Mayo (Patently-O) (Patent Baristas) (Patents4Life) (Holman's Biotech IP Blog) (Patent Docs) (Inventive Step) (Patently-O) Mircera (Recombinant erythropoietin) – US: CAFC: Section 121 ‘safe harbor’ provision does not apply to continuations:… [read post]
